Monday , October 23 2017
Home / Resources / Exclusive Interviews / Targeted Treatments for Mediating Pathways of Hyperglycemia

Targeted Treatments for Mediating Pathways of Hyperglycemia

stanley_schwartzIn part three of this special interview with DIC publisher Steve Freed, Dr. Stanley Schwartz discusses how the new beta-cell classification supports a patient-centric, “precision medicine” approach to diabetes care, and enables more targeted treatments for hyperglycemia.

Fill out my online form.
Use Wufoo integrations and get your data to your favorite apps.

View the complete video series of this special interview with Dr. Schwartz:

Part 1: Defining the Classifications of the New System

Part 2: Beta-Cell Construct: Egregious Eleven

Part 3: Targeted Treatments for Mediating Pathways of Hyperglycemia

Part 4: Individualization of Patient Care

Part 5: The Beta-Cell is Final Common Denominator of Beta-Cell Damage

Part 6: New Classification for Monogenic and Pre-Diabetes

Part 7: Supporters of New Classification of Diabetes

You can find all of Dr. Schwartz’s Diabetes In Control articles and videos as well as his biography here.